Stephen Hawking and ALS

The average duration of this disease is 27 to 43 months. So he stands to gain about three months of life on Relyutec, a single bonus season. According to his most optimistic calculations, he won't see his 50th birthday. Although Richard hasn't reached a definitive decision on a tracheostomy yet, if he had to choose today, he would rather die than rely on invasive ventilation. The inspirational speech aimed to fuel his will to live and persevere.